Tarbox Family Office’s Pacira BioSciences PCRX Stock Holding History

Tarbox Family Office’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-30	Closed	-$2K	–	1188
2021 Q1	$2K	Hold	30	–	–	﹤0.01%	916
2020 Q4	$2K	Sell	30 -9	-23%	-$527	﹤0.01%	873
2020 Q3	$2K	Hold	39	–	–	﹤0.01%	821
2020 Q2	$2K	Buy	+39	New	+$1.63K	﹤0.01%	807
2020 Q1	–	Sell	-37	Closed	-$2K	–	1262
2019 Q4	$2K	Buy	+37	New	+$1.57K	﹤0.01%	828

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Tarbox Family Office's PCRX Position: Q2 2021 in Review

Tarbox Family Office sold out of Pacira BioSciences (PCRX) in Q2 2021, closing a stake of 30 shares — an estimated $2K sold.

Tarbox Family Office first reported a position in PCRX in Q4 2019 and held it in 5 quarters. The position peaked at $2K in Q1 2021. 262 funds tracked by Wall St. Rank hold PCRX as of Q2 2021.

Tarbox Family Office reported no remaining Pacira BioSciences position as of Q2 2021 after selling out during the quarter.
Tarbox Family Office sold 30 Pacira BioSciences shares in Q2 2021, an estimated $2K.
Tarbox Family Office first reported a position in Pacira BioSciences in Q4 2019 and held it in 5 quarters.
Tarbox Family Office's Pacira BioSciences position peaked at $2K in Q1 2021.
262 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2021.

Based on Tarbox Family Office's 13F filing for Q2 2021, filed 16 Jul 2021.